story of the week
Sequential First-Line Everolimus and Second-Line Sunitinib vs First-Line Sunitinib and Second-Line Everolimus in Patients With Metastatic RCC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase II Randomized Trial Comparing Sequential First-Line Everolimus and Second-Line Sunitinib Versus First-Line Sunitinib and Second-Line Everolimus in Patients With Metastatic Renal Cell Carcinoma
J. Clin. Oncol 2014 Sep 01;32(25)2765-72, RJ Motzer, CH Barrios, TM Kim, S Falcon, T Cosgriff, WG Harker, V Srimuninnimit, K Pittman, R Sabbatini, SY Rha, TW Flaig, R Page, S Bavbek, JT Beck, P Patel, FY Cheung, S Yadav, EM Schiff, X Wang, J Niolat, D Sellami, O Anak, JJ KnoxFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Renal Cell Carcinoma Center of Excellence
Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.